.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
Covington
Medtronic
Chubb
Fish and Richardson
Julphar
Cerilliant
Johnson and Johnson
Boehringer Ingelheim

Generated: December 15, 2017

DrugPatentWatch Database Preview

Pseudoephedrine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pseudoephedrine hydrochloride and what is the scope of pseudoephedrine hydrochloride freedom to operate?

Pseudoephedrine hydrochloride
is the generic ingredient in sixteen branded drugs marketed by Sanofi Aventis Us, Glaxosmithkline, Aurobindo Pharma Ltd, L Perrigo Co, Sun Pharm Inds Ltd, Mcneil Cons, J And J Consumer Inc, Kv Pharm, Cenci, Usl Pharma, Newtron Pharms, Pvt Form, Sandoz, Teva, Watson Labs, West Ward, Ivax Sub Teva Pharms, and Superpharm, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-nine drug master file entries for pseudoephedrine hydrochloride. Thirty-four suppliers are listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Newtron PharmsTRILITRONpseudoephedrine hydrochloride; triprolidine hydrochlorideSYRUP;ORAL088474-001Feb 12, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pvt FormALLERFEDpseudoephedrine hydrochloride; triprolidine hydrochlorideTABLET;ORAL088860-001Jan 31, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
CenciHISTAFEDpseudoephedrine hydrochloride; triprolidine hydrochlorideSYRUP;ORAL088283-001Apr 20, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GlaxosmithklineACTIFEDpseudoephedrine hydrochloride; triprolidine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL018996-001Jun 17, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsNOVAFEDpseudoephedrine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL017603-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Newtron PharmsTRILITRONpseudoephedrine hydrochloride; triprolidine hydrochlorideTABLET;ORAL088515-001Jan 9, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SuperpharmTRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDEpseudoephedrine hydrochloride; triprolidine hydrochlorideTABLET;ORAL088578-001Feb 21, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozCORPHEDpseudoephedrine hydrochloride; triprolidine hydrochlorideTABLET;ORAL088602-001Apr 11, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
CenciACTAHISTpseudoephedrine hydrochloride; triprolidine hydrochlorideSYRUP;ORAL088344-001Feb 9, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaTRIPHEDpseudoephedrine hydrochloride; triprolidine hydrochlorideTABLET;ORAL088630-001May 17, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: pseudoephedrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer IncSUDAFED 24 HOURpseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020021-002Dec 15, 1992► Subscribe► Subscribe
J And J Consumer IncSUDAFED 24 HOURpseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020021-002Dec 15, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Colorcon
Julphar
McKinsey
Mallinckrodt
Farmers Insurance
US Army
Deloitte
Daiichi Sankyo
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot